A Double-Blind, Randomized, 6-Month Evaluation of the Safety and Efficacy of Topical Alprostadil in Hysterectomized Women With Female Sexual Arousal Disorder (FSAD)
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2007
At a glance
- Drugs Alprostadil (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- Sponsors VIVUS
- 14 Jun 2007 Status changed from in progress to completed.
- 12 Nov 2006 New trial record.